Literature DB >> 10214035

[Seven cases of marked pulmonary fibrosis in the upper lobe].

S Shiota1, K Shimizu, M Suzuki, Y Nakaya, K Sakamoto, A Iwase, S Aoki, R Matsuoka, S Shimizu, Y Nagayama, Y Kawabata.   

Abstract

We report on 7 patients with marked idiopathic pulmonary fibrosis in the upper lung lobes. The patients were generally characterized by the following pathological and clinical features: (1) marked subpleural pulmonary opacities and reticular shadows mainly in the upper lobes, with a progressive reduction in lung volume; (2) nonspecific fibrosis (subpleural, zonal, rather well-defined fibrosis with small cysts and honeycomb lesions) in 5 patients and interstitial pneumonia in 2, mainly in the upper lobes; and (3) a slender build, and a family history of recurrent spontaneous pneumothorax. Clinically, all 7 cases resembled idiopathic upper-lobe fibrosis as described by Amitani in 1992. Further clinical and experimental research will be required to delineate the characteristics of idiopathic fibrosis affecting primarily the upper lobes.

Entities:  

Mesh:

Year:  1999        PMID: 10214035

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  12 in total

1.  Lower-lobe shrinkage relative to total lung volume in collagen vascular diseases.

Authors:  M Watanabe; T Igishi; N Burioka; J Kurai; Y Fukuoka; K Kato; A Yamasaki; Y Hasegawa; R Okazaki; E Shimizu
Journal:  Radiol Med       Date:  2010-06-23       Impact factor: 3.469

2.  Body Mass Index and arterial blood oxygenation as prognostic factors in patients with idiopathic pleuroparenchymal fibroelastosis.

Authors:  Hiroki Hayashi; Takahito Nei; Shinji Abe; Yoshinobu Saito; Nariaki Kokuho; Kenichiro Atsumi; Kazue Fujita; Takefumi Saito; Takahiro Tanaka; Akihiko Gemma; Arata Azuma
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

Review 3.  The pathogenesis and pathology of idiopathic pleuroparenchymal fibroelastosis.

Authors:  Yoshiaki Kinoshita; Hiroshi Ishii; Kazuki Nabeshima; Kentato Watanabe
Journal:  Histol Histopathol       Date:  2020-12-14       Impact factor: 2.303

4.  An observational study of giant cell interstitial pneumonia and lung fibrosis in hard metal lung disease.

Authors:  Junichi Tanaka; Hiroshi Moriyama; Masaki Terada; Toshinori Takada; Eiichi Suzuki; Ichiei Narita; Yoshinori Kawabata; Tetsuo Yamaguchi; Akira Hebisawa; Fumikazu Sakai; Hiroaki Arakawa
Journal:  BMJ Open       Date:  2014-03-27       Impact factor: 2.692

5.  Pleuroparenchymal Fibroelastosis: Its Pathological Characteristics.

Authors:  Jan H von der Thüsen
Journal:  Curr Respir Med Rev       Date:  2013-08

6.  Pleuroparenchymal Fibroelastosis: Its Clinical Characteristics.

Authors:  Kentaro Watanabe
Journal:  Curr Respir Med Rev       Date:  2013-06

Review 7.  Pleuroparenchymal Fibroelastosis. A Review of Clinical, Radiological, and Pathological Characteristics.

Authors:  Felix Chua; Sujal R Desai; Andrew G Nicholson; Anand Devaraj; Elisabetta Renzoni; Alexandra Rice; Athol U Wells
Journal:  Ann Am Thorac Soc       Date:  2019-11

8.  Idiopathic pleuroparenchymal fibroelastosis: consideration of a clinicopathological entity in a series of Japanese patients.

Authors:  Hideki Kusagaya; Yutaro Nakamura; Masato Kono; Yusuke Kaida; Shigeki Kuroishi; Noriyuki Enomoto; Tomoyuki Fujisawa; Naoki Koshimizu; Koshi Yokomura; Naoki Inui; Takafumi Suda; Thomas V Colby; Kingo Chida
Journal:  BMC Pulm Med       Date:  2012-12-05       Impact factor: 3.317

9.  Functional associations of pleuroparenchymal fibroelastosis and emphysema with hypersensitivity pneumonitis.

Authors:  Joseph Jacob; Arlette Odink; Anne Laure Brun; Claudio Macaluso; Angelo de Lauretis; Maria Kokosi; Anand Devaraj; Sujal Desai; Elisabetta Renzoni; Athol U Wells
Journal:  Respir Med       Date:  2018-03-30       Impact factor: 3.415

10.  The similarities and differences between pleuroparenchymal fibroelastosis and idiopathic pulmonary fibrosis.

Authors:  Hiroshi Ishii; Yoshiaki Kinoshita; Hisako Kushima; Nobuhiko Nagata; Kentaro Watanabe
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.